Guidance Offered for Improving Diversity in Multiple Myeloma Trials

WEDNESDAY, March 10, 2021 -- In an initiative from the Dana-Farber Cancer Institute in Boston, the U.S. Food and Drug Administration, and the American Association for Cancer Research, published online Feb. 18 in Blood Cancer Discovery,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news